ArticleJournal of clinical medicine2024

Genetic Risk of Ankylosing Spondylitis and Second-Line Therapy Need in Crohn's Disease: A Mendelian Randomization Study.

Mahmud Omar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.